Your search returned 5 results.

Results
	1.	Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease. [electronic resource] by Doménech, Marta Jové, Maria Aso, Samantha Marín, Mar Nadal, Ernest Producer: 20190624 In: Lung cancer (Amsterdam, Netherlands) vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution. [electronic resource] by España, Sofia Pérez Montes de Oca, Alejandra Marques-Pamies, Montserrat Cucurull, Marc Domenech, Marta Velarde, José María Salinas, Isabel Moran, Teresa Etxaniz, Olatz Publication details: Translational lung cancer research Feb 2020 In: Translational lung cancer research vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. [electronic resource] by García, Margarita Moreno, Rafael Gil-Martin, Marta Cascallò, Manel de Olza, Maria Ochoa Cuadra, Carmen Piulats, Josep Maria Navarro, Valentin Domenech, Marta Alemany, Ramon Salazar, Ramon Producer: 20200312 In: Human gene therapy vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients. [electronic resource] by Estival, Anna Sanz, Carolina Ramirez, Jose-Luis Velarde, Jose Maria Domenech, Marta Carrato, Cristina de Las Peñas, Ramón Gil-Gil, Miguel Sepúlveda, Juan Armengol, Roser Cardiel, Isaac Berrocal, Alfonso Luque, Raquel Herrero, Ana Balana, Carmen Producer: 20201028 In: Scientific reports vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01). [electronic resource] by Balana, Carmen Vaz, Maria Angeles Manuel Sepúlveda, Juan Mesia, Carlos Del Barco, Sonia Pineda, Estela Muñoz-Langa, Jose Estival, Anna de Las Peñas, Ramón Fuster, Jose Gironés, Regina Navarro, Luis Miguel Gil-Gil, Miguel Alonso, Miriam Herrero, Ana Peralta, Sergio Olier, Clara Perez-Segura, Pedro Covela, Maria Martinez-García, Maria Berrocal, Alfonso Gallego, Oscar Luque, Raquel Perez-Martín, Franciso Javier Esteve, Anna Munne, Nuria Domenech, Marta Villa, Salvador Sanz, Carolina Carrato, Cristina Producer: 20210426 In: Neuro-oncology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)